Member Info for KnockOutthePin

Hendi2, am I correct in thinking you are saying that AIM companies have to wait util the end of a Fin Qtr before announcing/RNS'ing orders?

What do we all think regarding an impending placement to raise cash. As no orders/rev/cash it has to come fairly soon and I believe the prediction was Sept/Oct?

LTH here - ironically considering Budd’s non- commercial approach, the best way to have managed a GDR investment over last 18mths has been to trade it based on hype rather than delivery of anything meaningful as they haven’t (delivered anything meaningful).

Going fwd I will be doing this and at c.50p I anticipate it will get hyped to various highs over next 6mths (notwithstanding the inevitable placement coming soon).

Do not however invest in GDR as a long term investment until Budd is removed.

IMO it's a terrific interview and remarkably open and candid. Of course she cannot release certain info but is going to great lengths to explain in detail what the issues are, what she is doing to address them, and is extremely reassuring to me. Geopolitical issues are a nightmare and are hard/impossible to address and care not one jot about ORCP or its shareholders so we have to live with that risk and hope ultimately we will be rewarded. I may even buy more/double down on the back of this to get my average down even though still many risks of delay - I’m patient (been here >18mths already)

Seems strange to me that although an extension rather than a new customer a significant order and the SP is actually down! Surely this is +ve news and good customer relationship that bodes well?

Yes I wondered that. Up 6.8% now so hopefully the start of the re-rate

My recollection was that Budd said in his last uninspiring update that they had not been able to get it into customer trials as they couldn’t talk F2F to NHS staff to sell - but he was hopeful they could now get their first two trial live customers in June.

Budd said they were looking to get first trials (and hopefully some orders!) in June but we’ve heard nothing. Anyone seen anything? To me it’s a more realistic hope of getting the SP back nearer to a £1.

It’s fine for me.

Great RNS - yes Budd’s idea of a supportive RNS that didn’t need releasing and results in-10%. He is clueless. And btw, I’m a TLTH - that’s Too LTH!

Yes it’s weird - like he really doesn’t want the SP to rise. P’raps if he had a bit more skin the game personally he might actually support investors. Or maybe he just can't write RNSs in a positive way?

And £100m and neutral news = SP at 360p?

Having invested and lost money serially on GDR for the last 14mths I am thinking it may now be the time to call it a day. After all the rhetoric; ‘Gold Standard’ Beckman, India (I think DIVOC is a bad joke btw - COVID backwards!) etc I can really only see a chance to make any profit now on the Hearing Test progressing in the UK (to start then broader) and as MC is still very low maybe I can get my current investment above water (115p). Or maybe the US DoD will perk up but don’t have any confidence really if I’m honest. I have been concerned for most of the time invested that Budd’s dependence and inability to generate revenue with channels was a big problem and so it has played out continually. I hope I am wrong and they finally sell something but a placement will have to come soon and after the appalling way that was handled last time I’d rather get out before then. The BoD need to review how other AIM companies have done placements in a well managed and seamless way and actually increased the SP as a result rather. I’ll give it a few more weeks and then I am done - GLA who are more recent investors (and less burnt).

We can!

Just fyi, tare was a Corporate Action on ii

Ditto

Thanks Jenkoo

Was up 8% Friday and now 13% today - anyone got any ideas on what is causing this? Most of you on here seem very -ve so not expecting too much constructive feedback :-)

I don’t blame people taking quick/small profits as this company is very high risk - has never displayed any consistent, reliable behaviour or proper BOD governance. Whilst I’m sure many investors think the prod has a big market - particularly atm in places like India many are really just looking to recover their losses I imagine. Hence all these short bursts rather than sustained growth in SP. That makes it very hairy to trade.

Assume you’ve seen the AVCT RNS - you want more content I assume.